| American Stem Cell Therapeutic |
| Lynnet Koh |
| www.americastemcell.com |
| Life Science |
| treatment to improve the success of cord blood stem cell transplants |
| ASC is a biopharmaceutical company developing an enzyme treatment for cord blood stem cells to enhance their homing and engraftment to target diseased organs, accelerate cell and organ regeneration and improve survival and quality of life outcomes for patients. This investment will enable Phase I/II clinical trials. |
